Results 141 to 150 of about 113,876 (211)

Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study. [PDF]

Sci Rep
Roig B, Fernández-Castillejo S, Gumà J, Badia J, Melé M, Salvat M, Querol M, Cumeras R, Rodríguez-Balada M.   +8 more
europepmc   +1 more source

Ovarian follicular density in women with BRCA1 and BRCA2 mutations: new insights into the negative impact on ovarian reserve. [PDF]

J Ovarian Res
Maletta M, Vicenti R, Forastiere C, Di Santo S, Doglioli M, Lenzi J, Raffone A, Cobellis L, Perandini A, Somigliana E, Seracchioli R, Raimondo D.   +11 more
europepmc   +1 more source

A BRCT domain-containing protein induced in early phagocytosis plays a crucial role in the pathogenesis of the mucoralean Rhizopus microsporus. [PDF]

PLoS Pathog
Tahiri G, Lax C, Binder U, Scheler J, Navarro E, Nicolás FE, Garre V.   +6 more
europepmc   +1 more source

Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2024". [PDF]

Hered Cancer Clin Pract
europepmc   +1 more source

Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. [PDF]

Commun Med (Lond)
Al Assaad M, Hadi K, Levine MF, Guevara D, Patel M, Tranquille M, King A, Otilano J, Semaan A, Gundem G, Medina-Martínez JS, Sigouros M, Manohar J, Kuo HH, Wilkes DC, Andreopoulou E, Chapman-Davis E, Tagawa ST, Sboner A, Ocean AJ, Shah MA, Papaemmanuil E, Sternberg CN, Holcomb K, Nanus DM, Elemento O, Mosquera JM.   +26 more
europepmc   +1 more source

Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo-Oophorectomy in BRCA1/2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center. [PDF]

Cancer Med
Mendes S, Yahiaoui-Doktor M, Fallenberg EM, Kiechle M, Grill S.   +4 more
europepmc   +1 more source

Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma. [PDF]

Breast J
Rao D, Wernecke C, Baron L, Cai S, Beitsch P, Patel R, Whitworth P, Rosen B, Tran NN, Hughes K, Baron PL.   +10 more
europepmc   +1 more source

IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression. [PDF]

Commun Med (Lond)
Weir AL, Lee SC, Li M, Pandey A, Tan CW, Garsed DW, Ramus SJ, Davidson NM.   +7 more
europepmc   +1 more source